Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Zoetis Inc. ZTS

Healthcare  —  Drug Manufacturers Specialty & Generic
71.05 0.78 1.11% as of 25 Sep
Market cap
$29.2B
P/E
11.7×
S&P 500 Member Dividend Champion (10y) Revenue Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Zoetis Inc. (ZTS) Debt to equity

Zoetis Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 2.9×, up 0.2× from fiscal 2025 (2.7×). Over the past ten years it has ranged from 1.3× (fiscal 2023) to 4.5× (fiscal 2015); the current reading is higher than 64% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.0× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Annual

Period Debt to equity Change
FY2025 2.7× 97.07%
FY2024 1.4× 4.68%
FY2023 1.3× (26.70%)
FY2022 1.8× 22.98%
FY2021 1.5× (23.50%)
FY2020 1.9× (19.86%)
FY2019 2.4× (19.38%)
FY2018 3.0× 6.48%
FY2017 2.8× (6.96%)
FY2016 3.0× (33.20%)

Quarterly

Period Debt to equity Change
Jun 2026 2.9× 2.73%
Mar 2026 2.8× 5.67%
Dec 2025 2.6× 102.18%
Sep 2025 1.3× (0.96%)
42 more quarters

Against its own ten years

Low 1.3× High 4.5×
Ten-year median 2.4×
Current reading's percentile 64

Debt to equity against peers

Company Debt to equity
UTHR United Therapeutics Corporation compare 0.0×
NBIX Neurocrine Biosciences, Inc. compare 0.0×
RDY Dr. Reddy's Laboratories Ltd compare 0.2×
HLN Haleon PLC Sponsored ADR compare 0.5×
ELAN Elanco Animal Health Incorporated compare 0.6×
TAK Takeda Pharmaceutical Co. compare 0.7×
VTRS Viatris Inc. compare 0.9×
TEVA Teva Pharmaceutical Industries Ltd. compare 2.1×
ZTS Zoetis Inc. 2.9×
Drug Manufacturers Specialty & Generic industry median 0.0×
Healthcare sector median 0.0×
Market median 0.2×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on ZTS